TechCrunch @TechCrunch
An offer they couldn’t refuse: MiroBio, a startup developing treatments for autoimmune patients, accepted an offer to be a part of @GileadSciences for $405M, @psawers reports. https://t.co/cVxhyxjZyZ — PolitiTweet.org
Created
Thu Aug 04 22:32:05 +0000 2022
Likes
2
Retweets
0
Source
Twitter Web App
View Raw Data
JSON DataView on Twitter
Likely Available
TechCrunch @TechCrunch
An offer they couldn’t refuse: MiroBio, a startup developing treatments for autoimmune patients, accepted an offer to be a part of @GileadSciences for $405M, @psawers reports. https://t.co/cVxhyxjZyZ — PolitiTweet.org